Campaign includes a $50,000 donation to Wounded Warriors by Spectrum
Therapeutics and an internal fundraiser to raise additional
contributions through November
SMITHS FALLS, ON, Oct. 28, 2020 /CNW/ - Canopy Growth Corporation
("Canopy Growth" or the "Company") (TSX:WEED) (NYSE:CGC), through
its medical division Spectrum Therapeutics, is honoured to announce
a donation campaign for the month of November in support of Wounded
Warriors Canada ("WWC") and its mental health services for Veterans
and First Responders.
In recognition of the immense contributions and sacrifices of
the Canadians who have and who continue to serve in uniform, and in
the leadup to Veterans Week and Remembrance Day, Spectrum
Therapeutics has made a $50,000
donation to WWC to support its mission to create resilience and
hope for ill and injured Veterans, First Responders, and their
families. In addition, Spectrum Therapeutics will be launching a
fundraiser, matching donations from its patients and staff through
the month of November up to an additional $20,000.
Due to the increased isolation and mental health impacts of
COVID-19, the need for Wounded Warriors' group-based trauma therapy
programs including Couples Overcoming PTSD Everyday, Spousal
Resiliency Program, and the Trauma Resiliency Program has increased
significantly. Donated funds will be used to help support the
delivery of these programs across Canada including through the month of
November.
"For our team at Wounded Warriors Canada, partnerships make our
mental health programs possible. We are grateful for the donation
by Spectrum Therapeutics and look forward to the life-changing
impact this contribution will have in the lives of our injured
Veterans, First Responders and their families," said Scott Maxwell, Executive Director, Wounded
Warriors Canada.
"We have great admiration for the team at Wounded Warriors
Canada who provide critical services to support Veterans, First
Responders, and their families including through the COVID 19
pandemic which has been especially difficult for those suffering
from isolation and mental health challenges" said Hilary Black, Chief Advocacy Officer, Canopy
Growth. "During this month of national remembrance, it is our great
privilege to support healing through WWC's national programs in
respect of the service and sacrifices of Canada's Veterans and first responders."
For Canadians interested in learning more or donating to support
Wounded Warriors Canada programming, please visit
https://woundedwarriors.ca/
Wounded Warriors Canada recognizes no one service, association,
government agency, or organization will ever be the 100% solution
for its members in need of mental health support. When a Veteran or
First Responder is struggling, it doesn't matter where, when or how
the injury occurred. What matters is that Veterans and First
Responders and their family members know that we are
#INTHISTOGETHER – working to ensure they receive the help they so
rightly deserve.
Spectrum Therapeutics and Wounded Warriors #INTHISTOGETHER
About Wounded Warriors Canada:
Wounded Warriors
Canada is a national mental health service provider utilizing
clinical best practices and evidence-based care to create an
environment of compassion, resiliency and hope for Canada's Veterans, First Responders and their
families.
About Spectrum Therapeutics
Spectrum Therapeutics,
the medical division of Canopy Growth Corporation (TSX: WEED, NYSE:
CGC), is dedicated to educating healthcare practitioners,
furthering the public's understanding of medical cannabis and its
various applications, and cutting edge, commercializable research
and IP development. Founded in Canada, Spectrum Therapeutics operates in
Australia, South America, Africa and across Europe. Its products are available in a wide
range of potencies and formats designed to simplify the dialogue
around strength and dosage by applying a colour-coded spectrum to
categorize medical cannabis according to THC and CBD levels.
Spectrum Therapeutics' offerings include whole flower cannabis,
oils and new innovations such as Softgels in addition to single
cannabinoid medicine Dronabinol under the brand Bionorica Ethics.
Through product simplification, robust clinical research and
ongoing education of healthcare professionals, Spectrum
Therapeutics is committed to addressing the unmet medical needs of
patients around the globe.
About Canopy Growth Corporation
Canopy Growth
(TSX:WEED, NYSE:CGC) is a world-leading diversified cannabis, hemp
and cannabis device company, offering distinct brands and curated
cannabis varieties in dried, oil and Softgel capsule forms, as well
as medical devices through Canopy Growth's subsidiary, Storz &
Bickel GMbH & Co. KG. From product and process innovation to
market execution, Canopy Growth is driven by a passion for
leadership and a commitment to building a world-class cannabis
company one product, site and country at a time.
Canopy Growth's medical division, Spectrum Therapeutics is
proudly dedicated to educating healthcare practitioners, conducting
robust clinical research, and furthering the public's understanding
of cannabis, and has devoted millions of dollars toward cutting
edge, commercializable research and IP development. Spectrum
Therapeutics sells a range of full-spectrum products using its
colour-coded classification Spectrum system as well as single
cannabinoid Dronabinol under the brand Bionorica Ethics.
Canopy Growth operates retail stores across Canada under its award-winning Tweed and Tokyo
Smoke banners. Tweed is a globally recognized cannabis brand which
has built a large and loyal following by focusing on quality
products and meaningful customer relationships.
From our historic public listing on the Toronto Stock Exchange
and New York Stock Exchange to our international expansion, pride
in advancing shareholder value through leadership is engrained in
all we do at Canopy Growth. Canopy Growth has established
partnerships with leading sector names including cannabis icons
Snoop Dogg and Seth Rogen, breeding
legends DNA Genetics and Green House Seeds, as well as lifestyle
guru Martha Stewart and Fortune 500
alcohol leader Constellation Brands, to name but a few. For
more information visit www.canopygrowth.com.
Notice Regarding Forward Looking Statements
This press
release contains "forward-looking statements" and "forward-looking
information" within the meaning of applicable U.S. and Canadian
securities laws (collectively, "forward-looking statements"), which
involve certain known and unknown risks and uncertainties.
Forward-looking statements predict or describe our future
operations, business plans, business and investment strategies and
the performance of our investments. These forward-looking
statements are generally identified by their use of such terms and
phrases as "intend," "goal," "strategy," "estimate," "expect,"
"project," "projections," "forecasts," "plans," "seeks,"
"anticipates," "potential," "proposed," "will," "should," "could,"
"would," "may," "likely," "designed to," "foreseeable future,"
"believe," "scheduled" and other similar expressions. You are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date the statement was
made. Forward–looking statements are necessarily based upon a
number of estimates and assumptions that, while considered
reasonable by management, are inherently subject to significant
business, economic and competitive risks, financial results,
results, performance or achievements expressed or implied by those
forward–looking statements and the forward–looking statements are
not guarantees of future performance. Accordingly, there are
or will be important factors that could cause actual outcomes or
results to differ materially from those indicated in these
statements. A discussion of some of the material factors applicable
to Canopy Growth Corporation ("Canopy") can be found under the
section entitled "Risk Factors" in Canopy's Annual Report on Form
10-K for the year ended March 31, 2020, filed with the
Securities and Exchange Commission and with applicable Canadian
securities regulators, as such factors may be further updated from
time to time in its periodic filings with the Securities and
Exchange Commission and with applicable Canadian securities
regulators, which can be accessed at www.sec.gov/edgar and
www.sedar.com, respectively. These factors should not be
construed as exhaustive and should be read in conjunction with the
other cautionary statements that are included in this press release
and in the filings. Any forward–looking statement included in this
press release is made as of the date of this press release and,
except as required by law, Canopy disclaims any
obligation to update or revise any forward– looking
statement. Readers are cautioned not to put undue reliance on
any forward–looking statement. Forward-looking statements contained
in this press release are expressly qualified by this cautionary
statement.
SOURCE Canopy Growth Corporation